# NFIA

## Overview
The NFIA gene encodes the nuclear factor I A (NFIA) protein, a transcription factor that belongs to the nuclear factor I (NFI) family. This family is characterized by a conserved N-terminal DNA-binding domain, which is essential for the protein's role in DNA replication and transcription regulation (Fletcher1999Exon). NFIA is involved in a variety of biological processes, including adipogenesis, where it regulates the differentiation of brown and beige adipocytes, and in the central nervous system, where it acts as a gliogenic switch to promote glial differentiation (Hiraike2020NFIA; Tchieu2019NFIA). The protein's ability to form homodimers or heterodimers and its interactions with other proteins and nucleic acids underscore its significance in gene regulation and cellular differentiation (Fletcher1999Exon). Mutations in the NFIA gene are associated with developmental disorders, particularly affecting the central nervous system and urinary tract, highlighting its critical role in human development (Bertini2022Phenotypic).

## Structure
The NFIA protein is a member of the nuclear factor I (NFI) family, which is characterized by a highly conserved N-terminal DNA-binding domain. This domain is crucial for the protein's function in DNA replication and transcription regulation (Fletcher1999Exon). The DNA-binding domain of NFIA is encoded by a single large exon, similar to other NFI family members, and is conserved across various species, including mammals and C. elegans (Fletcher1999Exon).

The NFIA protein can form homodimers or heterodimers, contributing to its quaternary structure, which is essential for its DNA-binding activity (Fletcher1999Exon). The C-terminal region of NFIA is less conserved and is subject to alternative splicing, resulting in multiple isoforms with potentially distinct functions (Osada2005Organization). These isoforms may have different roles in gene expression regulation during development (Fletcher1999Exon).

Post-translational modifications, such as phosphorylation, may occur in NFIA, influencing its activity and interactions (Fletcher1999Exon). The exon structure and evolutionary analysis suggest that the NFIA gene has undergone significant genomic changes over time, reflecting its adaptation and functional diversification (Fletcher1999Exon).

## Function
The NFIA gene encodes a transcription factor that plays a critical role in various cellular and developmental processes. In the context of adipogenesis, NFIA is essential for the differentiation of brown and beige adipocytes, which are involved in energy dissipation and heat generation. It regulates the expression of PPARγ, a key transcriptional regulator of adipogenesis, through its C-terminal pro#3 domain, which is crucial for binding to chromatin and activating adipocyte-specific gene expression (Hiraike2020NFIA). NFIA also suppresses myogenesis by repressing myogenic transcription factors such as Myod1 and Myog, ensuring the proper balance between adipocyte and muscle cell formation (Hiraike2020NFIA).

In the central nervous system, NFIA acts as a gliogenic switch, facilitating the transition from neurogenesis to gliogenesis. It is necessary for the induction of glial competency genes and the expression of GFAP, a marker for astrocytes, and plays a role in chromatin remodeling to promote glial differentiation (Deneen2006The; Tchieu2019NFIA). NFIA is also involved in the development of the CNS by influencing axon guidance, glial and neuronal cell differentiation, and neuronal migration (Mason2008Nuclear).

## Clinical Significance
Mutations and alterations in the NFIA gene are associated with several developmental disorders, primarily affecting the central nervous system and urinary tract. NFIA haploinsufficiency is linked to 'Chromosome 1p32p31 deletion syndrome', also known as 'brain malformations with or without urinary tract defects' (BRMUTD). This syndrome is characterized by macrocephaly, central nervous system malformations, developmental delay, intellectual disability, and facial dysmorphism (Bertini2022Phenotypic). Other clinical manifestations include corpus callosum abnormalities, ventriculomegaly, hydrocephalus, Chiari I malformation, seizures, and urinary tract defects (Revah‐Politi2017Loss‐of‐function; Labonne2016Comparative).

NFIA disruptions, whether through deletions, translocations, or point mutations, are associated with features such as macrocephaly and developmental delay (Revah‐Politi2017Loss‐of‐function). The gene's role in brain formation and urinary tract development is crucial, with functional defects potentially leading to abnormal brain formation and urinary tract defects (Zhang2020A). In some cases, NFIA haploinsufficiency has been linked to autism spectrum disorder and other behavioral abnormalities (Revah‐Politi2017Loss‐of‐function; Bertini2022Phenotypic). The variability in phenotypic expression among patients with NFIA deletions may be due to incomplete penetrance (Labonne2016Comparative).

## Interactions
NFIA (nuclear factor I A) is involved in various interactions with proteins and nucleic acids, playing a significant role in gene regulation. In glioblastoma cells, NFIA interacts with the NFκB p65 promoter, enhancing transcription and expression of NFκB p65, which contributes to cell survival by increasing anti-apoptotic factors (Lee2016A). NFIA also forms a feed-forward loop with NFκB p65, where both proteins regulate each other's transcription, contributing to glioblastoma cell survival and drug resistance (Lee2016A).

In the context of adipocyte differentiation, NFIA interacts with specific nucleic acid sequences, such as the Pparg enhancer, to promote PPARγ expression, crucial for adipogenesis. It also competes with KLF5 for binding to the Myod1 enhancer, repressing myogenesis (Hiraike2020NFIA). NFIA's pro#3 domain is essential for its transcriptional activity in adipogenesis but not required for repressing myogenesis (Hiraike2020NFIA).

In pancreatic development, NFIA regulates cell fate by interacting with the Mib1 promoter, affecting Notch signaling and influencing the balance between endocrine and ductal cell formation (Scavuzzo2018Pancreatic). NFIA also interacts with Olig2, where Olig2 can suppress NFIA's proastrocytic activity, indicating a direct protein-protein interaction (Deneen2006The).


## References


[1. (Revah‐Politi2017Loss‐of‐function) Anya Revah‐Politi, Mythily Ganapathi, Louise Bier, Megan T. Cho, David B. Goldstein, Parisa Hemati, Alejandro Iglesias, Jane Juusola, John Pappas, Slavé Petrovski, Ashley L. Wilson, Vimla S. Aggarwal, and Kwame Anyane‐Yeboa. Loss‐of‐function variants in nfia provide further support that nfia is a critical gene in 1p32‐p31 deletion syndrome: a four patient series. American Journal of Medical Genetics Part A, 173(12):3158–3164, September 2017. URL: http://dx.doi.org/10.1002/ajmg.a.38460, doi:10.1002/ajmg.a.38460. This article has 17 citations.](https://doi.org/10.1002/ajmg.a.38460)

[2. (Zhang2020A) Yan Zhang, Cai Mei Lin, Xiao Lan Zheng, and Kuerbanjiang Abuduxikuer. A novel nfia gene nonsense mutation in a chinese patient with macrocephaly, corpus callosum hypoplasia, developmental delay, and dysmorphic features. Molecular Genetics &amp; Genomic Medicine, September 2020. URL: http://dx.doi.org/10.1002/mgg3.1492, doi:10.1002/mgg3.1492. This article has 7 citations.](https://doi.org/10.1002/mgg3.1492)

[3. (Osada2005Organization) Shigehiro Osada, Masayoshi Imagawa, and Tsutomu Nishihara. Organization of gene structure and expression of nuclear factor 1 family in rat. DNA Sequence, 16(2):151–155, April 2005. URL: http://dx.doi.org/10.1080/10245170500059024, doi:10.1080/10245170500059024. This article has 2 citations.](https://doi.org/10.1080/10245170500059024)

[4. (Fletcher1999Exon) Colin F. Fletcher, Nancy A. Jenkins, Neal G. Copeland, Ali Z. Chaudhry, and Richard M. Gronostajski. Exon structure of the nuclear factor i dna-binding domain from c. elegans to mammals nfia ), af111264 ( nfib ), af111265 ( nfic ), af111266 ( nfix ).–&gt;. Mammalian Genome, 10(4):390–396, April 1999. URL: http://dx.doi.org/10.1007/s003359901008, doi:10.1007/s003359901008. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s003359901008)

[5. (Deneen2006The) Benjamin Deneen, Ritchie Ho, Agnes Lukaszewicz, Christian J. Hochstim, Richard M. Gronostajski, and David J. Anderson. The transcription factor nfia controls the onset of gliogenesis in the developing spinal cord. Neuron, 52(6):953–968, December 2006. URL: http://dx.doi.org/10.1016/j.neuron.2006.11.019, doi:10.1016/j.neuron.2006.11.019. This article has 534 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2006.11.019)

[6. (Mason2008Nuclear) Sharon Mason, Michael Piper, Richard M. Gronostajski, and Linda J. Richards. Nuclear factor one transcription factors in cns development. Molecular Neurobiology, 39(1):10–23, December 2008. URL: http://dx.doi.org/10.1007/s12035-008-8048-6, doi:10.1007/s12035-008-8048-6. This article has 85 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-008-8048-6)

[7. (Tchieu2019NFIA) Jason Tchieu, Elizabeth L. Calder, Sudha R. Guttikonda, Eveline M. Gutzwiller, Kelly A. Aromolaran, Julius A. Steinbeck, Peter A. Goldstein, and Lorenz Studer. Nfia is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells. Nature Biotechnology, 37(3):267–275, February 2019. URL: http://dx.doi.org/10.1038/s41587-019-0035-0, doi:10.1038/s41587-019-0035-0. This article has 161 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41587-019-0035-0)

[8. (Lee2016A) JunSung Lee, Edlira Hoxha, and Hae-Ri Song. A novel nfia-nfκb feed-forward loop contributes to glioblastoma cell survival. Neuro-Oncology, pages now233, December 2016. URL: http://dx.doi.org/10.1093/neuonc/now233, doi:10.1093/neuonc/now233. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/neuonc/now233)

[9. (Scavuzzo2018Pancreatic) Marissa A. Scavuzzo, Jolanta Chmielowiec, Diane Yang, Katrina Wamble, Lesley S. Chaboub, Lita Duraine, Burak Tepe, Stacey M. Glasgow, Benjamin R. Arenkiel, Christel Brou, Benjamin Deneen, and Malgorzata Borowiak. Pancreatic cell fate determination relies on notch ligand trafficking by nfia. Cell Reports, 25(13):3811-3827.e7, December 2018. URL: http://dx.doi.org/10.1016/j.celrep.2018.11.078, doi:10.1016/j.celrep.2018.11.078. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2018.11.078)

[10. (Hiraike2020NFIA) Yuta Hiraike, Hironori Waki, Kana Miyake, Takahito Wada, Misato Oguchi, Kaede Saito, Shuichi Tsutsumi, Hiroyuki Aburatani, Toshimasa Yamauchi, and Takashi Kadowaki. Nfia differentially controls adipogenic and myogenic gene program through distinct pathways to ensure brown and beige adipocyte differentiation. PLOS Genetics, 16(9):e1009044, September 2020. URL: http://dx.doi.org/10.1371/journal.pgen.1009044, doi:10.1371/journal.pgen.1009044. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1009044)

[11. (Bertini2022Phenotypic) Veronica Bertini, Francesca Cambi, Alessandro Orsini, Alice Bonuccelli, Aureliano Fiorini, Andrea Santangelo, Massimo Scacciati, Maurizio Elia, Ornella Galesi, Diego Peroni, and Angelo Valetto. Phenotypic spectrum of nfia haploinsufficiency: two additional cases and review of the literature. Genes, 13(12):2249, November 2022. URL: http://dx.doi.org/10.3390/genes13122249, doi:10.3390/genes13122249. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13122249)

[12. (Labonne2016Comparative) Jonathan D. J. Labonne, Yiping Shen, Il-Keun Kong, Michael P. Diamond, Lawrence C. Layman, and Hyung-Goo Kim. Comparative deletion mapping at 1p31.3-p32.2 implies nfia responsible for intellectual disability coupled with macrocephaly and the presence of several other genes for syndromic intellectual disability. Molecular Cytogenetics, March 2016. URL: http://dx.doi.org/10.1186/s13039-016-0234-z, doi:10.1186/s13039-016-0234-z. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13039-016-0234-z)